Overview

A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension

Status:
Completed

Trial end date:
2009-08-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the antihypertensive efficacy and safety of Fimasartan (BR-A-657•K) during 24 hours by dose in patients with mild to moderate essential hypertension.

Phase:

Phase 2

Details

Lead Sponsor:

Boryung Pharmaceutical Co., Ltd

Collaborators:

Catholic Medical Center
Chonnam National University Hospital
Inje University
Kyungpook National University
Kyungpook National University Hospital
Seoul National University Hospital

Treatments:

Antihypertensive Agents
Valsartan